• RESEARCH

    Early-onset rectal cancer with pMMR/MSS phenotype reported in patient with germline PMS2 variant

    A 41-year-old woman with low rectal adenocarcinoma showed retained MMR protein expression and microsatellite stability, yet germline testing confirmed a pathogenic PMS2 frameshift variant, illustrating that pMMR/MSS findings do not exclude hereditary risk in early-onset disease. (Front Med)